Mainz Biomed: Test revolutionizes colorectal cancer screening

Mainz is a city from which a number of major, groundbreaking innovations in the biotechnology and life sciences industry are emerging. The masterminds driving these advances are making a positive impact at the Mainz Life Science Hub. We will be showcasing these leading figures, their companies and institutions as well as their pioneering ideas and solutions in regular storytelling formats.

The first instalment in this series features the company Mainz Biomed, the developer of ColoAlert, a home screening test for colorectal cancer that is more accurate than comparable products. Dr Moritz Eidens (CSO and Director of Mainz Biomed) talks to Mike Peter Schweitzer (PR & Marketing Manager, biomindz GmbH) about what inspired him to develop the test, the motivation for his research and why ColoAlert could revolutionise the prevention of colorectal cancer.
 

Colorectal cancer: Early detection is better than treatment

Colorectal or bowel cancer is the third most common type of cancer and the likelihood of a complete recovery is high if detected at an early stage. The problem is that, even today, not enough people are undergoing colonoscopies; for many, the fear of this invasive procedure and the feeling of embarrassment are too great and waiting times are often long. Thanks to its ColoAlert home testing kit, Mainz Biomed provides a reliable alternative for those who would prefer a non-invasive cancer screening method.

Mainz Biomed: Concentrated knowledge from the city on the Rhine

Positive feedback from users is a constant source of motivation for Dr Moritz Eidens and his team. As a city of academia and science, Mainz has proven to be the ideal location for Biomed. Close ties to the University Medical Center and other biotech companies, the city's central location in Germany and Europe as well as excellent transport links combine to make the city on the river Rhine especially desirable for the life sciences industry.